Literature DB >> 19614702

Global prevalence of chronic migraine: a systematic review.

J L Natoli1, A Manack, B Dean, Q Butler, C C Turkel, L Stovner, R B Lipton.   

Abstract

The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.

Entities:  

Mesh:

Year:  2010        PMID: 19614702     DOI: 10.1111/j.1468-2982.2009.01941.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  164 in total

1.  Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).

Authors:  L M Bloudek; M Stokes; D C Buse; T K Wilcox; R B Lipton; P J Goadsby; S F Varon; A M Blumenfeld; Z Katsarava; J Pascual; M Lanteri-Minet; P Cortelli; P Martelletti
Journal:  J Headache Pain       Date:  2012-05-29       Impact factor: 7.277

2.  Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A?

Authors:  Calogera Butera; Bruno Colombo; Francesca Bianchi; Marco Cursi; Roberta Messina; Stefano Amadio; Roberta Guerriero; Giancarlo Comi; Ubaldo Del Carro
Journal:  Neurol Sci       Date:  2016-07-09       Impact factor: 3.307

Review 3.  Why do migraines often decrease as we age?

Authors:  Frederick G Freitag
Journal:  Curr Pain Headache Rep       Date:  2013-10

4.  Fibromyalgia comorbidity in a community sample of adults with migraine.

Authors:  Dawn A Marcus; Amrita Bhowmick
Journal:  Clin Rheumatol       Date:  2013-06-07       Impact factor: 2.980

5.  Complementary and conventional medicine use among youth with recurrent headaches.

Authors:  Christina Bethell; Kathi J Kemper; Narangerel Gombojav; Thomas K Koch
Journal:  Pediatrics       Date:  2013-10-14       Impact factor: 7.124

6.  Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse.

Authors:  Alberto Raggi; Ambra Mara Giovannetti; Silvia Schiavolin; Matilde Leonardi; Gennaro Bussone; Licia Grazzi; Susanna Usai; Marcella Curone; Paola Di Fiore; Domenico D'Amico
Journal:  Qual Life Res       Date:  2013-10-16       Impact factor: 4.147

7.  Can Circadian Dysregulation Exacerbate Migraines?

Authors:  Jason C Ong; Hannah L Taylor; Margaret Park; Helen J Burgess; Rina S Fox; Sarah Snyder; Jeanetta C Rains; Colin A Espie; James K Wyatt
Journal:  Headache       Date:  2018-05-04       Impact factor: 5.887

Review 8.  Functional imaging in chronic migraine.

Authors:  Farooq H Maniyar; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2013-05

Review 9.  Treatment of the Patient with Refractory Headache.

Authors:  Alessandro S Zagami
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

Review 10.  A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine.

Authors:  Amaal J Starling; Bert B Vargas
Journal:  Curr Pain Headache Rep       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.